10,000 results
·
34ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Analyzer, Data, Obstetric
FDA Pre-Market Approval
FDA Class 3
·STAN S31 SYSTEM
Analyzer, Data, Obstetric
FDA Pre-Market Approval
FDA Class 3
·STAN S31 FETAL HEART MONITOR
Analyzer, Data, Obstetric
FDA Pre-Market Approval
FDA Class 3
·STAN S31 FETAL HEART MONITOR
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE INJECTABLE GEL
Implant, Dermal, For Aesthetic Use
FDA Pre-Market Approval
FDA Class 3
·RESTYLANE
Test, Urea Adult And Pediatric (Breath),
FDA Pre-Market Approval
FDA Class 3
·BREATHTEK UBT FOR H.PYLORI KIT (BREATHTEK UBT KIT) AND PEDIATRIC UREA HYDROLYSIS RATE CALCULATION APPLICATION (PUHR-CA)
Stimulator, Neuromuscular, Implanted
FDA Pre-Market Approval
FDA Class 3
·NEUROCONTROL FREEHAND SYSTEM
Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation
FDA Pre-Market Approval
FDA Class 3
·ATRICURE SYNERGY ABLATION SYSTEM
Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation
FDA Pre-Market Approval
FDA Class 3
·Synergy Ablation System
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension Vista FPSA Flex reagent cartridge (K6452)
Implant, Anti-Gastroesophageal Reflux
FDA Pre-Market Approval
FDA Class 3
·LINX Reflux Management System
Implant, Anti-Gastroesophageal Reflux
FDA Pre-Market Approval
FDA Class 3
·LINX REGLUX MANAGEMENT SYSTEM
Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation
FDA Pre-Market Approval
FDA Class 3
·Synergy Ablation System
Kit, Assay, Progesterone Receptor
FDA Pre-Market Approval
FDA Class 3
·RIANEN(TM) (3H) PROGESTIN RECEPTOR ASSAY KIT
System, Test, Tumor Marker, For Detection Of Bladder Cancer
FDA Pre-Market Approval
FDA Class 3
·ALERE NMP22 BLADDERCHECK TEST & CONTROL KIT
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·Dimension FPSA Flex Reagent Cartridge